Cargando…
Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome
BACKGROUND: The expression of serine protease granzyme-B (GzmB) by circulating CD8(+) T lymphocytes has been recently suggested as a biomarker for poor immunotherapy response and severe disability in patients with Neuromyelitis Optica spectrum disorders (NMOSD). In parallel, venous thromboembolism (...
Autores principales: | Boldrini, Vinícius Oliveira, Brito, Mariana Rabelo, Quintiliano, Raphael Patrício Silva, Scárdua Silva, Lucas, Yasuda, Clarissa Lin, Cendes, Fernando, Farias, Alessandro Santos, Damasceno, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470460/ https://www.ncbi.nlm.nih.gov/pubmed/37662034 http://dx.doi.org/10.3389/fneur.2023.1208977 |
Ejemplares similares
-
Fatal neuromyelitis optica after COVID-19 vaccination
por: Boldrini, Vinícius de Oliveira, et al.
Publicado: (2022) -
No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis
por: Yang, Ting-Ting, et al.
Publicado: (2016) -
B lymphocytes in neuromyelitis optica
por: Bennett, Jeffrey L., et al.
Publicado: (2015) -
Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders
por: Shi, Ziyan, et al.
Publicado: (2022) -
AQP4ex is crucial for the anchoring of AQP4 at the astrocyte end-feet and for neuromyelitis optica antibody binding
por: Palazzo, Claudia, et al.
Publicado: (2019)